These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8549365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.
    Bassaris H, Akalin E, Calangu S, Kitzes R, Kosmidis J, Milicevic M, Noack H, Raz R, Salewski E, Sukalo M.
    Infection; 1995; 23(4):227-33. PubMed ID: 8522381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
    Ozaki M, Matsuda M, Tomii Y, Kimura K, Segawa J, Kitano M, Kise M, Shibata K, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
    [Abstract] [Full Text] [Related]

  • 7. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC.
    Curr Clin Top Infect Dis; 2000 Dec; 20():63-91. PubMed ID: 10943519
    [No Abstract] [Full Text] [Related]

  • 8. Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.
    Mattina R, Cocuzza CE, Cesana M.
    Infection; 1993 Dec; 21(2):106-11. PubMed ID: 8387963
    [Abstract] [Full Text] [Related]

  • 9. Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
    Tillotson G, Zhao X, Drlica K.
    Lancet Infect Dis; 2001 Oct; 1(3):145-6. PubMed ID: 11871490
    [No Abstract] [Full Text] [Related]

  • 10. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB, Pushkar' DIu, Rasner PI.
    Klin Med (Mosk); 2001 Oct; 79(12):35-8. PubMed ID: 11840809
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1988 Oct; 14(5):327-31. PubMed ID: 3219995
    [Abstract] [Full Text] [Related]

  • 12. [Ten-year experience with the use of ofloxacin (Tarivid*). New treatment regimens].
    Navashin SM, Navashin PS, Smirnova LB.
    Antibiot Khimioter; 1996 Oct; 41(9):99-103. PubMed ID: 9005800
    [No Abstract] [Full Text] [Related]

  • 13. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.
    Mavromanolakis E, Maraki S, Cranidis A, Tselentis Y, Kontoyiannis DP, Samonis G.
    Scand J Infect Dis; 2001 Oct; 33(6):477-8. PubMed ID: 11450873
    [Abstract] [Full Text] [Related]

  • 14. Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group.
    Krcmery S, Naber KG.
    Int J Antimicrob Agents; 1999 Feb; 11(2):133-8. PubMed ID: 10221416
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of ofloxacin--measurement of drug concentration in saliva of patients with impaired renal function.
    Fujita K, Matsuoka N, Takenaka I, Hiraishi K, Yokota T, Asahi T, Tatara K, Yuasa M, Kaifu Y, Kawano A.
    Drugs; 1995 Feb; 49 Suppl 2():312-3. PubMed ID: 8549345
    [No Abstract] [Full Text] [Related]

  • 16. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA.
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [Abstract] [Full Text] [Related]

  • 17. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW.
    Drugs; 1987 Feb; 34 Suppl 1():91-4. PubMed ID: 3481333
    [Abstract] [Full Text] [Related]

  • 18. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E, Bartoletti R, Trinchieri A, Rizzo M.
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [Abstract] [Full Text] [Related]

  • 19. Ofloxacin compared with ciprofloxacin in the treatment of complicated lower urinary tract infections.
    Kromann-Andersen B, Sommer P, Pers C, Larsen V, Rasmussen F.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():143-7. PubMed ID: 3182457
    [Abstract] [Full Text] [Related]

  • 20. Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin.
    Peters HJ.
    Infection; 1992 Sep; 20(3):172-3. PubMed ID: 1644496
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.